Logo

Jubilant Biosys Integrates PathArt Database with Spotfire DecisionSite

Sep 09, 2003

NEW YORK, Sept. 9 (GenomeWeb News) - Jubilant Biosys, a Bangalore, India-based bioinformatics firm, said today that it has integrated its PathArt database of signaling and metabolic pathways with Spotfire's DecisionSite analytic software.

Jubilant said it has developed a Spotfire "plug-in" that will allow users to map data analyzed with DecisionSite directly onto PathArt's more than 400 manually curated pathways.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.